Liver Diseases  >>  Victrelis (boceprevir)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Victrelis (boceprevir) / Roche, Merck (MSD)
NCT01443923: Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Terminated
4
4
US
Boceprevir, Peg-Interferon-alfa 2B, Ribavirin
National Institute of Allergy and Infectious Diseases (NIAID)
Hepatitis, HIV/AIDS
09/13
09/13
NCT01591460 / 2011-004810-41: A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C

Completed
4
165
Europe
boceprevir, peginterferon alfa-2a [Pegasys], ribavirin (Copegus]
Hoffmann-La Roche
Hepatitis C, Chronic
06/14
06/14
NCT01405027: Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy

Checkmark ACG 2013: OPTIMAL
Sep 2013 - Sep 2013: ACG 2013: OPTIMAL
Completed
4
197
US
Educational Intervention, Peg-Intron, Pegasys, Victrelis, Pegylated interferon alfa 2B, Pegylated interferon alfa 2A, Boceprevir, Ribavirin, Patient education and management skills training
Chronic Liver Disease Foundation, SCRI Development Innovations, LLC, Merck Sharp & Dohme LLC
Chronic Hepatitis C, Genotype 1
07/14
07/14
HIVCOBOC-RGT, NCT01925183 / 2012-005591-33: Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

Checkmark AASLD 2014: HIVCOBOC-RGT
Oct 2014 - Oct 2014: AASLD 2014: HIVCOBOC-RGT
Checkmark HIVCOBOC-RGT
Sep 2014 - Sep 2014: HIVCOBOC-RGT
Completed
4
6
Europe
Pegylated interferon alpha-2a, Pegasys®, Roche, Ribavirin, Copegus®, Roche, Boceprevir, Victrelis®, MSD
Markus Peck-Radosavljevic, Medical University of Vienna
Hepatitis C, Chronic, HIV
06/15
06/15
NCT01770223 / 2012-002771-33: A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113)

Withdrawn
4
0
NA
boceprevir, SCH 503034, PegIFN-2b, Peginterferon alfa-2b, PegIntron, SCH 054031, RBV, Ribavirin, Rebetol
Merck Sharp & Dohme LLC
Hepatitis C
12/15
12/15

Download Options